The clinical validity of miR-126 as a prognostic marker in epithelial ovarian cancer
Sign Up to like & getrecommendations! Published in 2023 at "Medicine"
DOI: 10.1097/md.0000000000033085
Abstract: Background: Ovarian cancer is the leading cause of gynecological cancer related death in females worldwide. Our previous study demonstrated that decreased expression of microRNA (miR-126) promoted ovarian cancer angiogenesis and invasion by targeting VEGF-A. This… read more here.
Keywords: cancer; ovarian cancer; clinical validity; validity mir ... See more keywords